I just don't understand the head count no being reduced due to the failed trial.
This is the ONLY honest clue as to what is going on.
There is only one answer to your observation.
The answer is Management is in talks with a SERIOUS partner. A partner that will essentially take over and properly fund future research and development.
Think about the increase in authorized shares to 500,000,000.